{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T11:06:07Z","timestamp":1793444767252,"version":"4.5.0"},"reference-count":116,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Tertiary lymphoid structures (TLS) are ectopic lymphoid structures that form in non-lymphoid tissues in response to chronic inflammatory stimulation. Structurally and functionally resembling lymph nodes, TLS are primarily composed of B cells, T cells, dendritic cells, and other immune cell populations. Critically, TLS serve as direct sites for initiating anti-tumor immune responses. Within tumors, TLS facilitate the accumulation of immune cells\u2014particularly effector subsets such as cytotoxic T cells and antibody-producing B cells\u2014in the tumor microenvironment, thereby establishing a localized hub for both cellular and humoral immunity. This localized immune activation correlates with improved patient prognosis and enhanced responses to immunotherapy. In this review, we summarize the organization, formation drivers, detection markers, and the interplay between TLS and tumor-associated genes. Furthermore, we discuss the potential of TLS as biomarkers for immunotherapy efficacy and their translational clinical applications.<\/jats:p>","DOI":"10.3389\/fonc.2025.1616904","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T04:13:43Z","timestamp":1747887223000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["The pivotal role of tertiary lymphoid structures in the tumor immune microenvironment"],"prefix":"10.3389","volume":"15","author":[{"given":"Chengsen","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiandong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14235968","article-title":"Tertiary lymphoid structures: A potential biomarker for anti-cancer therapy","volume":"14","author":"Zou","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40364-023-00460-1","article-title":"Roles and mechanisms of tumour-infiltrating B cells in human cancer: a new force in immunotherapy","volume":"11","author":"Zhang","year":"2023","journal-title":"Biomark Res"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2023.02.017","article-title":"B cells in the tumor microenvironment: Multi-faceted organizers, regulators, and effectors of anti-tumor immunity","volume":"41","author":"Laumont","year":"2023","journal-title":"Cancer Cell"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1097\/CJI.0b013e3181b91c9c","article-title":"Tumor secretion of VEGF induces endothelial cells to suppress T cell functions through the production of PGE2","volume":"33","author":"Mulligan","year":"2010","journal-title":"J Immunother"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2014.09.006","article-title":"Tertiary lymphoid structures in cancer and beyond","volume":"35","author":"Dieu-Nosjean","year":"2014","journal-title":"Trends Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2024.102504","article-title":"B cells spatial organization defines their phenotype and function in cancer \"Tell me with whom you consort, and I will tell you who you are\" - Goethe","volume":"91","author":"Bod","year":"2024","journal-title":"Curr Opin Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.83578","article-title":"Single-cell analysis reveals dynamics of human B cell differentiation and identifies novel B and antibody-secreting cell intermediates","volume":"12","author":"Verstegen","year":"2023","journal-title":"Elife"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/imm.13176","article-title":"V(D)J recombination, somatic hypermutation and class switch recombination of immunoglobulins: mechanism and regulation","volume":"160","author":"Chi","year":"2020","journal-title":"Immunology"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-2762","article-title":"Tumor-infiltrating plasma cells are associated with tertiary lymphoid structures, cytolytic T-cell responses, and superior prognosis in ovarian cancer","volume":"22","author":"Kroeger","year":"2016","journal-title":"Clin Cancer Res"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201309-1611OC","article-title":"Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer","volume":"189","author":"Germain","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-0081","article-title":"A strong B-cell response is part of the immune landscape in human high-grade serous ovarian metastases","volume":"23","author":"Montfort","year":"2017","journal-title":"Clin Cancer Res"},{"key":"B12","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ccell.2017.12.004","article-title":"Clinical sequencing defines the genomic landscape of metastatic colorectal cancer","volume":"33","author":"Yaeger","year":"2018","journal-title":"Cancer Cell"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-03144-0","article-title":"IgA transcytosis and antigen recognition govern ovarian cancer immunity","volume":"591","author":"Biswas","year":"2021","journal-title":"Nature"},{"key":"B14","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.immuni.2022.02.001","article-title":"Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer","volume":"55","author":"Meylan","year":"2022","journal-title":"Immunity"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2931-3","article-title":"Defining HPV-specific B cell responses in patients with head and neck cancer","volume":"597","author":"Wieland","year":"2021","journal-title":"Nature"},{"key":"B16","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1158\/0008-5472.CAN-12-1377","article-title":"Neogenesis of lymphoid structures and antibody responses occur in human melanoma metastases","volume":"72","author":"Cipponi","year":"2012","journal-title":"Cancer Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-0234","article-title":"CD20+ tumor-infiltrating lymphocytes have an atypical CD27- memory phenotype and together with CD8+ T cells promote favorable prognosis in ovarian cancer","volume":"18","author":"Nielsen","year":"2012","journal-title":"Clin Cancer Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e1512458","DOI":"10.1080\/2162402X.2018.1512458","article-title":"B cells in esophago-gastric adenocarcinoma are highly differentiated, organize in tertiary lymphoid structures and produce tumor-specific antibodies","volume":"8","author":"Schl\u00f6\u00dfer","year":"2018","journal-title":"Oncoimmunology"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.169.4.1829","article-title":"Antigen-driven oligoclonal expansion of tumor-infiltrating B cells in infiltrating ductal carcinoma of the breast","volume":"169","author":"Coronella","year":"2002","journal-title":"J Immunol"},{"key":"B20","article-title":"Antigen-driven clonal proliferation, somatic hypermutation, and selection of B lymphocytes infiltrating human ductal breast carcinomas","volume":"63","author":"Nzula","year":"2003","journal-title":"Cancer Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e12830","DOI":"10.1111\/sji.12830","article-title":"Tumour-associated B cells in urothelial urinary bladder cancer","volume":"91","author":"Zirakzadeh","year":"2020","journal-title":"Scand J Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"13083","DOI":"10.1038\/s41598-019-49581-4","article-title":"Increased regulatory B cells are involved in immune evasion in patients with gastric cancer","volume":"9","author":"Murakami","year":"2019","journal-title":"Sci Rep"},{"key":"B23","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.oraloncology.2015.11.003","article-title":"CD19(+)IL-10(+) regulatory B cells affect survival of tongue squamous cell carcinoma patients and induce resting CD4(+) T cells to CD4(+)Foxp3(+) regulatory T cells","volume":"53","author":"Zhou","year":"2016","journal-title":"Oncol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/nature24302","article-title":"Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity [published correction appears in Nature. 2017 Dec 21;552(7685):430. doi: 10.1038\/nature25028.] [published correction appears in Nature. 2018 Sep;561(7721):E1. doi: 10.1038\/s41586-018-0304-y","volume":"551","author":"Shalapour","year":"2017","journal-title":"Nature"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/s1471-4906(02)02302-5","article-title":"Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes","volume":"23","author":"Mantovani","year":"2002","journal-title":"Trends Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.678127","article-title":"B cell orchestration of anti-tumor immune responses: A matter of cell localization and communication","volume":"9","author":"Kinker","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-15-1408","article-title":"PD-1hi identifies a novel regulatory B-cell population in human hepatoma that promotes disease progression","volume":"6","author":"Xiao","year":"2016","journal-title":"Cancer Discov"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22115736","article-title":"Hijacked immune cells in the tumor microenvironment: molecular mechanisms of immunosuppression and cues to improve T cell-based immunotherapy of solid tumors","volume":"22","author":"Balta","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241914928","article-title":"The immune regulatory role of adenosine in the tumor microenvironment","volume":"24","author":"Xing","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B30","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41568-023-00560-y","article-title":"Dynamics and specificities of T cells in cancer immunotherapy","volume":"23","author":"Oliveira","year":"2023","journal-title":"Nat Rev Cancer"},{"key":"B31","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.immuni.2019.12.007","article-title":"Regulatory T cells restrain interleukin-2- and blimp-1-dependent acquisition of cytotoxic function by CD4+ T cells","volume":"52","author":"\u015aledzi\u0144ska","year":"2020","journal-title":"Immunity"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-13-1342","article-title":"Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cells","volume":"74","author":"Goc","year":"2014","journal-title":"Cancer Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-0952","article-title":"Characterization of chemokines and adhesion molecules associated with T cell presence in tertiary lymphoid structures in human lung cancer","volume":"71","author":"de Chaisemartin","year":"2011","journal-title":"Cancer Res"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1701269","article-title":"Immune cell infiltration and tertiary lymphoid structures as determinants of antitumor immunity","volume":"200","author":"Engelhard","year":"2018","journal-title":"J Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-2590","article-title":"Occurrence of tertiary lymphoid tissue is associated with T-cell infiltration and predicts better prognosis in early-stage colorectal cancers","volume":"20","author":"Di Caro","year":"2014","journal-title":"Clin Cancer Res"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.4161\/onci.28976","article-title":"Tertiary lymphoid structures in human lung cancers, a new driver of antitumor immune responses","volume":"3","author":"Goc","year":"2014","journal-title":"Oncoimmunology"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01639","article-title":"Spoiling for a fight: B lymphocytes as initiator and effector populations within tertiary lymphoid organs in autoimmunity and transplantation","volume":"8","author":"Alsughayyir","year":"2017","journal-title":"Front Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.immuni.2019.11.014","article-title":"Immune landscape of viral- and carcinogen-driven head and neck cancer","volume":"52","author":"Cillo","year":"2020","journal-title":"Immunity"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.cell.2020.07.005","article-title":"Coordinated Cellular Neighborhoods Orchestrate Antitumoral Immunity at the Colorectal Cancer Invasive Front [published correction appears in Cell. 2020 Oct 29;183(3):838. doi: 10.1016\/j.cell.2020.10.021","volume":"182","author":"Sch\u00fcrch","year":"2020","journal-title":"Cell"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-019-0144-6","article-title":"Tertiary lymphoid structures in the era of cancer immunotherapy","volume":"19","author":"Saut\u00e8s-Fridman","year":"2019","journal-title":"Nat Rev Cancer"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-20-0432","article-title":"Insights into tumor-associated tertiary lymphoid structures: novel targets for antitumor immunity and cancer immunotherapy","volume":"8","author":"Rodriguez","year":"2020","journal-title":"Cancer Immunol Res"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-2926","article-title":"Orchestration and prognostic significance of immune checkpoints in the microenvironment of primary and metastatic renal cell cancer","volume":"21","author":"Giraldo","year":"2015","journal-title":"Clin Cancer Res"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-0457-0","article-title":"Tertiary lymphoid structures in cancer - considerations for patient prognosis","volume":"17","author":"Munoz-Erazo","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/978-1-4939-8709-2_7","article-title":"Defining high endothelial venules and tertiary lymphoid structures in cancer","volume":"1845","author":"Jones","year":"2018","journal-title":"Methods Mol Biol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.21147\/j.issn.1000-9604.2022.04.05","article-title":"Tertiary lymphoid structure patterns predicted anti-PD1 therapeutic responses in gastric cancer","volume":"34","author":"Jiang","year":"2022","journal-title":"Chin J Cancer Res"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2023.02.002","article-title":"High endothelial venules in cancer: Regulation, function, and therapeutic implication","volume":"41","author":"Vella","year":"2023","journal-title":"Cancer Cell"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.736670","article-title":"High endothelial venules: A vascular perspective on tertiary lymphoid structures in cancer","volume":"12","author":"Vella","year":"2021","journal-title":"Front Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2022.2153911","article-title":"High endothelial venules proportion in tertiary lymphoid structure is a prognostic marker and correlated with anti-tumor immune microenvironment in colorectal cancer","volume":"55","author":"Zhan","year":"2023","journal-title":"Ann Med"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2017.101","article-title":"The immune contexture in cancer prognosis and treatment","volume":"14","author":"Fridman","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/nri1786","article-title":"Lymphoid neogenesis in chronic inflammatory diseases","volume":"6","author":"Aloisi","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.123.322136","article-title":"Lessons of vascular specialization from secondary lymphoid organ lymphatic endothelial cells","volume":"132","author":"Arroz-Madeira","year":"2023","journal-title":"Circ Res"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2000873","article-title":"Tertiary lymphoid structures: diversity in their development, composition, and role","volume":"206","author":"Gago da Gra\u00e7a","year":"2021","journal-title":"J Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-023-00706-z","article-title":"The roles of tertiary lymphoid structures in chronic diseases","volume":"19","author":"Sato","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1172\/JCI67428","article-title":"CD4+ follicular helper T cell infiltration predicts breast cancer survival","volume":"123","author":"Gu-Trantien","year":"2013","journal-title":"J Clin Invest"},{"key":"B55","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jhep.2018.09.003","article-title":"Intra-tumoral tertiary lymphoid structures are associated with a low risk of early recurrence of hepatocellular carcinoma","volume":"70","author":"Calderaro","year":"2019","journal-title":"J Hepatol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1126\/science.abf9419","article-title":"Tertiary lymphoid structures in cancer","volume":"375","author":"Schumacher","year":"2022","journal-title":"Science"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201510-2031OC","article-title":"Intratumoral immune cell densities are associated with lung adenocarcinoma gene alterations","volume":"194","author":"Mansuet-Lupo","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-0163","article-title":"TP53, STK11, and EGFR mutations predict tumor immune profile and the response to anti-PD-1 in lung adenocarcinoma","volume":"24","author":"Biton","year":"2018","journal-title":"Clin Cancer Res"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.693234","article-title":"Prognostic significance of gene signature of tertiary lymphoid structures in patients with lung adenocarcinoma","volume":"11","author":"Feng","year":"2021","journal-title":"Front Oncol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2022.11.001","article-title":"The impact of tertiary lymphoid structures on clinicopathological, genetic and gene expression characteristics in lung adenocarcinoma","volume":"174","author":"Tamiya","year":"2022","journal-title":"Lung Cancer"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.21037\/tlcr-20-457","article-title":"Molecular gene mutation profiles, TMB and the impact of prognosis in Caucasians and east Asian patients with lung adenocarcinoma","volume":"9","author":"Gu","year":"2020","journal-title":"Transl Lung Cancer Res"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2017-0029","article-title":"Distinct tertiary lymphoid structure associations and their prognostic relevance in HER2 positive and negative breast cancers","volume":"22","author":"Liu","year":"2017","journal-title":"Oncologist"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.868155","article-title":"The presence of tertiary lymphoid structures provides new insight into the clinicopathological features and prognosis of patients with breast cancer","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1309\/AJCPIXUYDVZ0RZ3G","article-title":"Prognostic significance of tumor-infiltrating lymphocytes and the tertiary lymphoid structures in HER2-positive breast cancer treated with adjuvant trastuzumab","volume":"144","author":"Lee","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.32982","article-title":"12-Chemokine signature, a predictor of tumor recurrence in colorectal cancer","volume":"147","author":"Tokunaga","year":"2020","journal-title":"Int J Cancer"},{"key":"B66","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41368-020-00092-3","article-title":"Prognostic value of tertiary lymphoid structure and tumour infiltrating lymphocytes in oral squamous cell carcinoma","volume":"12","author":"Li","year":"2020","journal-title":"Int J  Sci"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1378844","article-title":"Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer","volume":"7","author":"Posch","year":"2017","journal-title":"Oncoimmunology"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer","volume":"417","author":"Davies","year":"2002","journal-title":"Nature"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.629519","article-title":"Cutaneous melanoma: mutational status and potential links to tertiary lymphoid structure formation","volume":"12","author":"Salem","year":"2021","journal-title":"Front Immunol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1914-8","article-title":"Tertiary lymphoid structures improve immunotherapy and survival in melanoma [published correction appears in Nature. 2020 Apr;580(7801):E1. doi: 10.1038\/s41586-020-2155-6","volume":"577","author":"Cabrita","year":"2020","journal-title":"Nature"},{"key":"B71","doi-asserted-by":"publisher","first-page":"21530","DOI":"10.1038\/s41598-020-78560-3","article-title":"Pan-cancer analysis of genomic properties and clinical outcome associated with tumor tertiary lymphoid structure","volume":"10","author":"Lin","year":"2020","journal-title":"Sci Rep"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2017.07.005","article-title":"Tumor-infiltrating lymphocytes in breast cancer according to tumor subtype: Current state of the art","volume":"35","author":"Solinas","year":"2017","journal-title":"Breast"},{"key":"B73","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.canlet.2019.02.027","article-title":"BRCA gene mutations do not shape the extent and organization of tumor infiltrating lymphocytes in triple negative breast cancer","volume":"450","author":"Solinas","year":"2019","journal-title":"Cancer Lett"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-00565-9","article-title":"Tumor-infiltrating lymphocytes in the immunotherapy era","volume":"18","author":"Paijens","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.08.006","article-title":"Regulatory T cells in tumor-associated tertiary lymphoid structures suppress anti-tumor T cell responses","volume":"43","author":"Joshi","year":"2015","journal-title":"Immunity"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-17-0131","article-title":"Treg depletion licenses T cell-driven HEV neogenesis and promotes tumor destruction","volume":"5","author":"Colbeck","year":"2017","journal-title":"Cancer Immunol Res"},{"key":"B77","doi-asserted-by":"publisher","first-page":"e003883","DOI":"10.1136\/jitc-2021-003883","article-title":"Unique characteristics of tertiary lymphoid structures in kidney clear cell carcinoma: prognostic outcome and comparison with bladder cancer","volume":"10","author":"Masuda","year":"2022","journal-title":"J Immunother Cancer"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2015.1008791","article-title":"Understanding high endothelial venules: Lessons for cancer immunology","volume":"4","author":"Ager","year":"2015","journal-title":"Oncoimmunology"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1905301116","article-title":"Immunofibroblasts are pivotal drivers of tertiary lymphoid structure formation and local pathology","volume":"116","author":"Nayar","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109422","article-title":"Immune mechanisms orchestrate tertiary lymphoid structures in tumors via cancer-associated fibroblasts","volume":"36","author":"Rodriguez","year":"2021","journal-title":"Cell Rep"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00714","article-title":"Shared and unique features distinguishing follicular T helper and regulatory cells of peripheral lymph node and peyer's patches","volume":"9","author":"Georgiev","year":"2018","journal-title":"Front Immunol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.immuni.2021.12.007","article-title":"TGF-\u03b2-mediated silencing of genomic organizer SATB1 promotes Tfh cell differentiation and formation of intra-tumoral tertiary lymphoid structures","volume":"55","author":"Chaurio","year":"2022","journal-title":"Immunity"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.10.004","article-title":"T follicular helper cell differentiation, function, and roles in disease","volume":"41","author":"Crotty","year":"2014","journal-title":"Immunity"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.0284","article-title":"Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures","volume":"26","author":"Dieu-Nosjean","year":"2008","journal-title":"J Clin Oncol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3889\/oamjms.2018.341","article-title":"Tertiary lymphoid structures in colorectal cancers and their prognostic value","volume":"6","author":"Trajkovski","year":"2018","journal-title":"Open Access Maced J Med Sci"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.14657","article-title":"Tertiary lymphoid structures in colorectal cancer liver metastases: association with immunological and clinical parameters and chemotherapy response","volume":"40","author":"Ahmed","year":"2020","journal-title":"Anticancer Res"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.694079","article-title":"The 12-CK score: global measurement of tertiary lymphoid structures","volume":"12","author":"Li","year":"2021","journal-title":"Front Immunol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-021-03067-3","article-title":"The clinical significance of tertiary lymphoid structure and its relationship with peripheral blood characteristics in patients with surgically resected non-small cell lung cancer: a single-center, retrospective study","volume":"71","author":"Fukuhara","year":"2022","journal-title":"Cancer Immunol Immunother"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2015.145","article-title":"Intratumoral tertiary lymphoid organ is a favourable prognosticator in patients with pancreatic cancer","volume":"112","author":"Hiraoka","year":"2015","journal-title":"Br J Cancer"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1002\/JLB.5MA0322-746R","article-title":"Relationship and prognostic significance of IL-33, PD-1\/PD-L1, and tertiary lymphoid structures in cervical cancer","volume":"112","author":"Zhang","year":"2022","journal-title":"J Leukoc Biol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1038\/nri3298","article-title":"HEVs, lymphatics and homeostatic immune cell trafficking in lymph nodes","volume":"12","author":"Girard","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2020.1747339","article-title":"Tumor-associated tertiary lymphoid structure predicts postoperative outcomes in patients with primary gastrointestinal stromal tumors","volume":"9","author":"Lin","year":"2020","journal-title":"Oncoimmunology"},{"key":"B93","doi-asserted-by":"publisher","first-page":"4186","DOI":"10.1038\/s41467-019-12160-2","article-title":"B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma","volume":"10","author":"Griss","year":"2019","journal-title":"Nat Commun"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy218","article-title":"Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC)","volume":"29","author":"Cottrell","year":"2018","journal-title":"Ann Oncol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1906-8","article-title":"B cells are associated with survival and immunotherapy response in sarcoma","volume":"577","author":"Petitprez","year":"2020","journal-title":"Nature"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-1086-y","article-title":"Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma","volume":"26","author":"Gao","year":"2020","journal-title":"Nat Med"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2019.1583547","article-title":"APC germline hepatoblastomas demonstrate cisplatin-induced intratumor tertiary lymphoid structures","volume":"8","author":"Morcrette","year":"2019","journal-title":"Oncoimmunology"},{"key":"B98","doi-asserted-by":"publisher","first-page":"e001187","DOI":"10.1136\/jitc-2020-001187","article-title":"A new role for circulating T follicular helper cells in humoral response to anti-PD-1 therapy","volume":"8","author":"S\u00e1nchez-Alonso","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-1987","article-title":"Germinal centers determine the prognostic relevance of tertiary lymphoid structures and are impaired by corticosteroids in lung squamous cell carcinoma","volume":"78","author":"Sili\u0146a","year":"2018","journal-title":"Cancer Res"},{"key":"B100","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41379-018-0113-8","article-title":"Presence of tertiary lymphoid structures determines the level of tumor-infiltrating lymphocytes in primary breast cancer and metastasis","volume":"32","author":"Lee","year":"2019","journal-title":"Mod Pathol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3290","article-title":"Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma","volume":"16","author":"Finkin","year":"2015","journal-title":"Nat Immunol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1200\/JCO.2012.43.4589","article-title":"Gene expression-based model using formalin-fixed paraffin-embedded biopsies predicts overall survival in advanced-stage classical Hodgkin lymphoma","volume":"31","author":"Scott","year":"2013","journal-title":"J Clin Oncol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.10.030","article-title":"Distribution and density of tertiary lymphoid structures predict clinical outcome in intrahepatic cholangiocarcinoma","volume":"76","author":"Ding","year":"2022","journal-title":"J Hepatol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"e20200851","DOI":"10.1084\/jem.20200851","article-title":"B cells and cancer: To B or not to B","volume":"218","author":"Fridman","year":"2021","journal-title":"J Exp Med"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1922-8","article-title":"B cells and tertiary lymphoid structures promote immunotherapy response","volume":"577","author":"Helmink","year":"2020","journal-title":"Nature"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-12-256065","article-title":"Lymphotoxin-alpha contributes to lymphangiogenesis","volume":"116","author":"Mounzer","year":"2010","journal-title":"Blood"},{"key":"B108","doi-asserted-by":"publisher","first-page":"R118","DOI":"10.1186\/ar2326","article-title":"Increased lymphangiogenesis in joints of mice with inflammatory arthritis","volume":"9","author":"Zhang","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"B109","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.immuni.2006.06.016","article-title":"Recruitment and activation of naive T cells in the islets by lymphotoxin beta receptor-dependent tertiary lymphoid structure","volume":"25","author":"Lee","year":"2006","journal-title":"Immunity"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1016\/s1074-7613(00)80199-5","article-title":"BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis","volume":"12","author":"Luther","year":"2000","journal-title":"Immunity"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.169.1.424","article-title":"Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis","volume":"169","author":"Luther","year":"2002","journal-title":"J Immunol"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1097\/CMR.0000000000000439","article-title":"Lymphoid aggregates in desmoplastic melanoma have features of tertiary lymphoid structures","volume":"28","author":"Stowman","year":"2018","journal-title":"Melanoma Res"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.18464","article-title":"Features and clinical significance of tertiary lymphoid structure in cutaneous squamous cell carcinoma","volume":"36","author":"Wu","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41577-018-0084-5","article-title":"The immunological anatomy of the skin","volume":"19","author":"Kabashima","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1038\/s41385-020-00368-1","article-title":"The intestinal neuro-immune axis: crosstalk between neurons, immune cells, and microbes","volume":"14","author":"Jacobson","year":"2021","journal-title":"Mucosal Immunol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2022.101703","article-title":"Activation of B cells in Tertiary Lymphoid Structures in cancer: Anti-tumor or anti-self","volume":"65","author":"Fridman","year":"2023","journal-title":"Semin Immunol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1616904\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T04:13:44Z","timestamp":1747887224000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1616904\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,22]]},"references-count":116,"alternative-id":["10.3389\/fonc.2025.1616904"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1616904","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,22]]},"article-number":"1616904"}}